ACT Genomics- Committed to turning genomic data into actionable cancer solutions.

1. Comprehensive Genomic Profiling  

• For all solid tumors
• Evaluates targeted, immune, hormone and chemo therapy
• Predicts immunotherapy responses
• Screens 440 cancer-related genes

2. Targeted Genomic Profiling   

• For lung cancer and other solid tumors
• Evaluates targeted therapy
• Screens 40 druggable genes

3. Fusion Gene Testing   

• For all solid tumors
• Evaluates targeted therapy
• Screens 31 fusion genes and 182 transcripts

4. BRCA Testing   

• For ovarian cancer, breast cancer and other solid tumors
• Evaluates PARP inhibitors
• Screens BRCA1/2 and HRR related genes